Identification of pubic arch interference in prostate brachytherapy: Simplifying the transrectal ultrasound technique

Brachytherapy

Volumn 2, Issue 4, 2003, Pages 240-245

  Henderson, Alastair ^a,b,c   Laing, Robert W ^a   Langley, Stephen E M ^a  

^a St Luke's Cancer Centre   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Androgen deprivation; Brachytherapy; LHRH; Prostate cancer; Pubic arch interference

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PUBIC BONE; RADIATION DOSE DISTRIBUTION; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; PUBIC BONE; RADIOTHERAPY DOSAGE; ULTRASONOGRAPHY;

EID: 1542328955     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2003.11.001     Document Type: Article

References (16)

1. Langley S.E., Laing R. Prostate brachytherapy has come of age: A review of the technique and results. BJU Int. 89:2002;241-249.
2. Peschel R., King C., Roberts K. Pubic arch interference in permanent prostate implant patients. J Brachytherapy Intl. 14:1998;241-248.
3. Grimm P.D., Blasko J., Ragde H. Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early stage prostate cancer. 1994;Saunders, Philadelphia.
4. Wallner K., Ellis W., Russell K., et al. Use of TRUS to predict pubic arch interference of prostate brachytherapy. Int J Radiat Oncol Biol Phys. 43:1999;583-585.
5. Strang J.G., Rubens D.J., Brasacchio R.A., et al. Real-time US versus CT determination of pubic arch interference for brachytherapy. Radiology. 219:2001;387-393.
6. 3: Dosimetric analysis of implant quality. Int J Radiat Oncol Biol Phys. 46:2000;1199-1204.
7. Prestidge B.R., Prete J.J., Buchholz T.A., et al. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys. 40:1998;461-465.
8. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 44:1999;789-799.
9. Ash D., Flynn A., Battermann J., et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol. 57:2000;315-321.
10. Kang S.K., Chou R.H., Dodge R.K., et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys. 50:2001;937-945.
11. Lee N., Wuu C.S., Brody R., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 48:2000;1457-1460.
12. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 47:2000;353-360.
13. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 45:1999;59-67.
14. Grimm P., Blasko J., Ragde H. Transperineal ultrasound guided I-125/Pd-103 brachytherapy in the management of localized prostate cancer: Update of the clinical experience at seven years. Int J Radiat Oncol Biol Phys. 39:1997;219.
15. Kucway R., Vicini F., Huang R., et al. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol. 167:2002;2443-2447.
16. Tincher S.A., Kim R.Y., Ezekiel M.P., et al. Effects of pelvic rotation and needle angle on pubic arch interference during transperineal prostate implants. Int J Radiat Oncol Biol Phys. 47:2000;361-363.